2022
DOI: 10.15326/jcopdf.2022.0290
|View full text |Cite
|
Sign up to set email alerts
|

Circulating 1,3-Beta-D-Glucan is Associated with Lung Function, Respiratory Symptoms, and Mediators of Matrix Degradation in Chronic Obstructive Pulmonary Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 58 publications
0
3
0
Order By: Relevance
“…To date, definition of an appropriate cut‐off for fungal translocation is lacking. 4 Thus, relying upon a high cut‐off value, such as 80 pg/mL, provides a more conservative estimate of the utility of the BDG titre where a significant relationship with outcome, symptom severity or another biomarker was also observed in various other non‐fungal infection disease states [e.g., CKD, inflammatory bowel disease, COPD, Lupus 21 , 22 , 23 , 24 ].…”
Section: Methodsmentioning
confidence: 99%
“…To date, definition of an appropriate cut‐off for fungal translocation is lacking. 4 Thus, relying upon a high cut‐off value, such as 80 pg/mL, provides a more conservative estimate of the utility of the BDG titre where a significant relationship with outcome, symptom severity or another biomarker was also observed in various other non‐fungal infection disease states [e.g., CKD, inflammatory bowel disease, COPD, Lupus 21 , 22 , 23 , 24 ].…”
Section: Methodsmentioning
confidence: 99%
“…Patients with COPD have distinct gut microbiome profiles from healthy controls, with plausible causal mechanisms involving alternations of microbial metabolism [6 ▪ ]. Clinical observations also implicate translocation in severe COPD, as patients with acute exacerbations have increased small intestinal permeability, while plasma levels of 1,3-β- d -glucan (BDG), a fungal cell-wall constituent, potentially signifying translocating fungi from the gut), correlate with lung matrix degradation markers and worse lung function [7 ▪ ,8].…”
Section: Gut–lung Axis In Chronic Lung Diseasesmentioning
confidence: 99%
“…The prototypical PAMP is lipopolysaccharide (LPS), the endotoxin found on the outer cell wall of gram-negative bacteria, which causes increased neutrophil migration, higher myeloperoxidase activity, and cytokine levels in the lungs leading to epithelial cell damage and permeability alveolar edema [42,43]. Among critically ill patients without evidence of invasive fungal infection, plasma levels of the fungal PAMP BDG were significantly associated with the marker of intestinal permeability intestinal fatty acid binding protein-2, the hyper-inflammatory subphenotype of systemic host responses, higher mortality and longer times for liberation from mechanical ventilation [7 ▪ ,44 ▪▪ ]. Such studies provide indirect evidence of the role of gut-origin circulating PAMPs on lung physiology and outcomes.…”
Section: Translocation Of Microbial Components and Metabolitesmentioning
confidence: 99%